Rabies vaccines: where do we stand, where are we heading?

Rabies vaccines: where do we stand, where are we heading?

Item
http://www.wikidata.org/entity/Q38263028
Rabies Control and Treatment: From Prophylaxis to Strategies with Curative PotentialDevelopment of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.Rabies vaccine development by expression of recombinant viral glycoprotein.Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.Commentary: Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.Molecular and Cellular Dynamics in the Skin, the Lymph Nodes, and the Blood of the Immune Response to Intradermal Injection of Modified Vaccinia Ankara Vaccine.Four Thousand Years of Concepts Relating to Rabies in Animals and Humans, Its Prevention and Its Cure
P2860

Rabies vaccines: where do we stand, where are we heading?

Item
http://www.wikidata.org/entity/Q38263028
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Rabies vaccines: where do we stand, where are we heading?
@en
type
label
Rabies vaccines: where do we stand, where are we heading?
@en
prefLabel
Rabies vaccines: where do we stand, where are we heading?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Rabies vaccines: where do we stand, where are we heading?
@en
P2093
P2860
P304
P31
P356
10.1586/14760584.2015.973403
P433
P478
P50
P577
P698
P921